Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.

Verdejo-García AJ, López-Torrecillas F, Aguilar de Arcos F, Pérez-García M.

Addict Behav. 2005 Jan;30(1):89-101.

PMID:
15561451
2.

Drug-related decrease in neuropsychological functions of abstinent drug users.

van Holst RJ, Schilt T.

Curr Drug Abuse Rev. 2011 Mar;4(1):42-56. Review.

PMID:
21466500
3.

Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Verdejo-García A, López-Torrecillas F, Giménez CO, Pérez-García M.

Neuropsychol Rev. 2004 Mar;14(1):1-41. Review.

PMID:
15260137
6.

[Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse].

Verdejo-García A, Pérez-García M, Sánchez-Barrera M, Rodriguez-Fernández A, Gómez-Río M.

Rev Neurol. 2007 Apr 1-15;44(7):432-9. Review. Spanish.

7.

What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

Fernández-Serrano MJ, Pérez-García M, Verdejo-García A.

Neurosci Biobehav Rev. 2011 Jan;35(3):377-406. doi: 10.1016/j.neubiorev.2010.04.008. Epub 2010 May 6. Review.

PMID:
20451551
8.

Investigating the neurocognitive deficits associated with chronic drug misuse.

Rogers RD, Robbins TW.

Curr Opin Neurobiol. 2001 Apr;11(2):250-7. Review.

PMID:
11301247
9.

[Review: executive functioning and cannabis use].

Almeida PP, Novaes MA, Bressan RA, Lacerda AL.

Rev Bras Psiquiatr. 2008 Mar;30(1):69-76. Review. Portuguese.

10.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
11.

Understanding drug addiction: a neuropsychological perspective.

Yücel M, Lubman DI, Solowij N, Brewer WJ.

Aust N Z J Psychiatry. 2007 Dec;41(12):957-68. Review.

PMID:
17999268
12.

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.

Gouzoulis-Mayfrank E, Daumann J.

J Psychopharmacol. 2006 Mar;20(2):188-93. Review.

PMID:
16510477
13.

The neuropsychology of ecstasy (MDMA) use: a quantitative review.

Zakzanis KK, Campbell Z, Jovanovski D.

Hum Psychopharmacol. 2007 Oct;22(7):427-35. Review.

PMID:
17896346
14.

Neuropsychological assessment of substance abusers: review and recommendations.

Miller L.

J Subst Abuse Treat. 1985;2(1):5-17. Review.

PMID:
3900432
15.

[Neuropsychological impairment in the early Alzheimer's disease].

Traykov L, Rigaud AS, Cesaro P, Boller F.

Encephale. 2007 May-Jun;33(3 Pt 1):310-6. Review. French.

PMID:
17675928
16.
17.

Are the cognitive deficits associated with impaired insight in schizophrenia specific to executive task performance?

Donohoe G, Corvin A, Robertson IH.

J Nerv Ment Dis. 2005 Dec;193(12):803-8. Review.

PMID:
16319702
18.

The residual neuropsychological effects of cannabis: the current status of research.

Pope HG Jr, Gruber AJ, Yurgelun-Todd D.

Drug Alcohol Depend. 1995 Apr;38(1):25-34. Review.

PMID:
7648994
19.

"Loss of control" in alcoholism and drug addiction: a neuroscientific interpretation.

Lyvers M.

Exp Clin Psychopharmacol. 2000 May;8(2):225-49. Review.

PMID:
10843306
20.

Imaging cognitive deficits in drug abuse.

Lundqvist T.

Curr Top Behav Neurosci. 2010;3:247-75. doi: 10.1007/7854_2009_26. Review.

PMID:
21161756

Supplemental Content

Support Center